Ryan Specialty (NYSE:RYAN – Get Free Report) had its price target reduced by investment analysts at UBS Group from $55.00 to $52.00 in a research note issued to investors on Monday, Benzinga reports. The firm presently has a “buy” rating on the stock. UBS Group‘s price objective points to a potential upside of 14.35% from the stock’s previous close.
A number of other analysts have also weighed in on RYAN. Piper Sandler lowered their target price on Ryan Specialty from $48.00 to $40.00 and set a “neutral” rating for the company in a research note on Tuesday, October 6th. Cantor Fitzgerald upped their price target on shares of Ryan Specialty from $34.00 to $41.00 and gave the stock a “neutral” rating in a research report on Monday, August 3rd. Royal Bank Of Canada decreased their price objective on shares of Ryan Specialty from $55.00 to $52.00 and set an “outperform” rating on the stock in a report on Friday. Barclays raised their price objective on shares of Ryan Specialty from $46.00 to $48.00 and gave the company an “overweight” rating in a research report on Friday, July 31st. Finally, Keefe, Bruyette & Woods raised their price objective on shares of Ryan Specialty from $48.00 to $54.00 and gave the company an “outperform” rating in a research report on Friday, July 31st. Eight investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $52.15.
View Our Latest Report on RYAN
Ryan Specialty Price Performance
Shares of NYSE:RYAN traded up $1.63 on Monday, hitting $45.47. The stock had a trading volume of 2,434,540 shares, compared to its average volume of 2,200,786. Ryan Specialty has a twelve month low of $29.28 and a twelve month high of $58.94. The company has a debt-to-equity ratio of 4.03, a quick ratio of 1.00 and a current ratio of 1.01. The firm’s 50 day moving average price is $40.42 and its 200-day moving average price is $39.17. The company has a market capitalization of $11.63 billion, a price-to-earnings ratio of 56.14, a price-to-earnings-growth ratio of 0.90 and a beta of 0.54.
Ryan Specialty (NYSE:RYAN – Get Free Report) last posted its quarterly earnings data on Thursday, October 29th. The company reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.49 by $0.02. Ryan Specialty had a net margin of 8.25% and a return on equity of 47.77%. The company had revenue of $789.96 million during the quarter, compared to analyst estimates of $792.99 million. During the same quarter last year, the business posted $0.47 earnings per share. On average, equities research analysts predict that Ryan Specialty will post 2.17 earnings per share for the current year.
Institutional Trading of Ryan Specialty
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Vancity Investment Management Ltd bought a new stake in shares of Ryan Specialty in the 2nd quarter valued at $621,000. Guardian Point Capital LP increased its holdings in shares of Ryan Specialty by 15.0% in the first quarter. Guardian Point Capital LP now owns 575,000 shares of the company’s stock worth $19,400,000 after acquiring an additional 75,000 shares in the last quarter. Bank of America Corp DE increased its holdings in shares of Ryan Specialty by 34.8% in the first quarter. Bank of America Corp DE now owns 1,508,083 shares of the company’s stock worth $50,883,000 after acquiring an additional 389,505 shares in the last quarter. Vulcan Value Partners LLC raised its position in shares of Ryan Specialty by 20.0% during the second quarter. Vulcan Value Partners LLC now owns 7,912,669 shares of the company’s stock worth $298,782,000 after purchasing an additional 1,317,334 shares during the period. Finally, Confluence Investment Management LLC lifted its holdings in shares of Ryan Specialty by 64.6% during the 3rd quarter. Confluence Investment Management LLC now owns 311,140 shares of the company’s stock valued at $11,512,000 after purchasing an additional 122,139 shares in the last quarter. 84.82% of the stock is currently owned by institutional investors and hedge funds.
Ryan Specialty Company Profile
Ryan Specialty Holdings, Inc is a specialty insurance services company that provides wholesale brokerage, managing general underwriting and delegated authority solutions. The company works with retail insurance brokers, agents, carriers and other market participants to place and manage complex, specialty risks that may require specialized underwriting expertise or customized coverage.
Its business includes specialty insurance and reinsurance brokerage, underwriting management and insurance program administration.
Recommended Stories
- Five stocks we like better than Ryan Specialty
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AIāThese 5 Stocks Are Getting Paid
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.
